Fundamentals in the clinical management of intoxication due to smoke inhalation;Bases para el manejo clínico de la intoxicaciÓn por humo de incendios

Emergencias

Volumn 22, Issue 5, 2010, Pages 384-394

  Dueñas Laita, Antonio ^a   Putze, Guillermo Burillo ^b   Alonso, José Ramón ^c   Bajo, Ángel ^d   Climent, Benjamín ^e   Corral, Ervigio ^f   Felices, Francisco ^g   Ferrer, Ana ^h   del Pilar Hernández Frutos, María ⁱ   Nogué, Santiago ^c   Puiguriguer, Jordi ^j  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d Universidad de Salamanca   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^f Grupo Español de Reanimación Cardiopulmonar Pediátrica y Neonatal   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^h HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

ⁱ Unidad Militar de Emergencias   (Spain)

^j HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

more..

Author keywords

Carbon monoxide; Cyanuric acid; Fire; Hydroxocobalamin; Smoke

Indexed keywords

EID: 79953001886     PISSN: 11376821     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Hantson P, Benaissa L, Baud F. Intoxication par les fumees d'incendie. Presse Med. 1999;28:1949-54.
2. Pane GA, Mohler SR, Hamilton GC. The Cincinnati DC-9 experience: lessons in aircraft and airport safety. Aviat Space Environ Med. 1985;56:457-61.
3. Mégabarne B. Hidroxicobalamina como antídoto de elección en la intoxicación por cianuro en la inhalación de humo de incendio: un paso más para demostrar su eficacia. Emergencias. 2010;22:3-5.
4. Bona MA, Tomás ML, Sanz CL, Castellano M. Mort par intoxication. Statistiques de l'Institut Medico-Legal de Saragosse 1965-1982. J Med Legale. 1984;27:407-16.
5. Dueñas Laita A, Nogué Xarau S. Intoxicación por el humo de los incendios: tratamiento antidótico a base de vitaminas. Med Clin (Barc). 2000;114:658-60.
6. Dueñas Laita A, Nogué S, Burillo G, Castrodeza J. Disponibilidad en los hospitales españoles del antídoto hidroxocobalamina para intoxicados por humo. Med Clin (Barc). 2008;131:318-9.
7. Alarie Y. Toxicity of fire smoke. Crit Rev Toxicol. 2002;32:259-89.
8. Barriot P, Riou B. Intoxication par fumées d'incendie. En: Danel V, Barriot P. Intoxications aiguës en réanimation. Rueil-Malmaison: Arnette. 1999; pp. 169-83.
9. Lee-Chiong TL. Smoke inhalation injury. Postgrad Med. 1999;105:55-62.
10. Clark CJ, Campbell D, Reid WH. Blood carboxyhaemoglobin and cyanide levels in fire survivors. Lancet. 1981;1:1332-35.
11. Ansell M, Lewis FAS. A record of cyanide concentrations found in human organs. J Forens Sci. 1970;17:148-55.
12. Birky MM, Clarke FB. Inhalation of toxic products from fires. Bull N Y Acad Med. 1981;57:997-1013.
13. Baud FJ, Barriot P, Toffis V, Riou B, Vicaut E, Lecarpentier Y, et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Eng J Med. 1991;325:1761.
14. Corral Torres E, Suárez Bustamante R, Gómez Granizo E, Casado Florez MI, Giménez Mediavilla JJ, De Elías Hernández R. Hidroxicabalamina y niveles séricos de lactato en la sospecha de intoxicación por cianuro en el síndrome de inhalación de humos. Emergencias. 2010;22:9-17.
15. Eckstein M, Maniscalco PM. Focus on smoke inhalation--the most common cause of acute cyanide poisoning. Prehosp Disaster Med. 2006;21:s49-55.
16. Dueñas A, Pérez JL, Martín Escudero JC. Novedades en la intoxicación por humo de incendios. En: Net Castel A, Marruecos-Sant L. Intoxicaciones agudas graves. Barcelona: Ars Médica; 2006. pp. 103-100.
17. Dueñas-Laita A, Peréz-Castrillón JL, Ruiz-Mambrilla M. Heart disease deaths among firefighters. N Engl J Med. 2007;356:2535-7.
18. Kirk MA, Holstege CP. Smoke inhalation. En: Goldfrank LR, Flomenbaum EN, Lewin NA, Weisman RS, Howland MA, Hoffman RS, editores. Toxicologic emergencies. Stamford: Appleton & Lange; 1998. pp. 1539-49.
19. Manual de Procedimientos SAMUR Protección Civil. En: www.munimadrid.es/samur. Procedimiento de Manejo del paciente con intoxicación por humos. Madrid: SAMUR-Protección Civil; 2009.
20. Weaver LK. Hyperbaric oxygen in carbon monoxide poisoning. Conflicting evidence that it works. Br Med J. 1999;319:1083-4.
21. Hart GB, Strauss MB, Lennon PA, Whithcraft DD. Treatment of smoke inhalation by hyperbaric oxygen. J Emerg Med. 1985;3:211-5.
22. Meyer GW, Hart GB, Strauss MB. Hyperbaric oxygen therapy for acute smoke inhalation injuries. Postgrad Med. 1991;89:221-3.
23. Weaver LK, Hopkins RO, Chan KJ, Churchill S, Elliott CG, Clemmer TP, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. 2002;47:1057-67.
24. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med. 2007;49:794-801.
25. FDA Approves Drug to Treat Cyanide Poisoning. (Consultado 11 Febrero 2010): Disponible en: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01531.html.
26. Hydroxocobalamin. (Consultado 11 Febrero 2010). Disponible en: http://www.pmda.go.jp/english/
27. EPARs for authorised medicinal products for human use. Cyanokit: European Public Assessment Report. (Consultado 11 Febrero 2010). Disponible en http://www.emea.europa.eu/humandocs/Humans/EPAR/cyanokit/cyanokit.htm.
28. Nogué S, Puiguriguer J, Amigó M. Indicadores de calidad para la asistencia urgente de pacientes con intoxicaciones agudas (CALITOX-2006). (Consultado 11 Febrero 2010). Disponible en: http://wzar.unizar.es/stc/actividades/actividades.html.
29. Burillo-Putze G, Nogue-Xarau S, Duenas-Laita A. Another antidote to acute cyanide poisoning. Pediatr Crit Care Med. 2006;7:611.
30. Hall AH, Saiers J, Baud F. Which cyanide antidote? Crit Rev Toxicol. 2009;39:541-52.
31. Hall AH, Kulig KW, Rumack BH. Suspected cyanide poisoning in smoke inhalation: complications of sodium nitrite therapy. J Toxicol Clin Exp. 1989;9:3-9.
32. Aaron CK. Cyanide antidotes. En: Goldfrank LR, Flomenbaum EN, Lewin NA, Weisman RS, Howland MA, Hoffman RS, editores. Toxicologic emergencies. Stamford: Appleton & Lange; 1998. pp. 1583-5.
33. Kerns W 2nd, Beuhler M, Tomaszewski C. Hydroxocobalamin versus thiosulfate for cyanide poisoning. Ann Emerg Med. 2008;51:338-9.
34. Pickering WG. Cyanide toxicity and the hazards of dicobalt edetate. Br Med J. 1985;291:1644.
35. Riou B, Berdeaux A, Pussard E, Giudicelli JF. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intensive Care Med 1993;19:26-32.
36. Shepherd G, Velez LI. Role of hydroxocobalamin in acute cyanide poisoning. Ann Pharmacother. 2008;42:661-9.
37. Forsyth JC, Mueller PD, Becker CE, Osterloh J, Benowitz NL, Rumack BH, et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol. 1993;31:277-94.
38. Houeto P, Hoffman JR, Imbert M, Levillain P, Baud FJ. Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning. Lancet. 1995;346:605-8.
39. Houeto P, Borron SW, Sandouk P, Imbert M, Levillain P, Baud FJ. Pharmacokinetics of hydroxocobalamin in smoke inhalation victims. J Toxicol Clin Toxicol. 1996;34:397-404.
40. Hall AH, Rumack BH. Hydroxocobalamin/sodium thiosulfate as a cyanide antidote. J Emerg Med. 1987;5:115-121.
41. Riou B, Baud FJ. L'hydroxocobalamine. JEUR. 1997;2:68-75.
42. Borron SW, Stonerook M, Reid F. Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol (Phila). 2006;44(Supl. 1):5-15.
43. Uhl W, Nolting A, Golor G, Rost KL, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol (Phila). 2006;44(Supl. 1):17-28.
44. Fortin JL, Ruttimann M, Capellier G, Bigorie A, Ferlicot S, Thervet E. Successful organ transplantation after treatment of fatal cyanide poisoning with hydroxocobalamin. Clin Toxicol (Phila). 2007;45:468-71.
45. Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol (Phila). 2006;44(Supl. 1):37-44.
46. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med. 2007;49:794-801.
47. Beckerman N, Leikin SM, Aitchinson R, Yen M, Wills BK. Laboratory interferences with the newer cyanide antidote: hydroxocobalamin. Semin Diagn Pathol. 2009;26:49-52.
48. Borron SW, Uhl W, Nolting A, Hostalek U. Interference of the cyanide antidote hydroxocobalamin with carboxyhemoglobin measurements should not limit clinical use in suspected or confirmed cyanide poisoning. Ann Emerg Med. 2007;50:624-5.
49. Borron SW, Baud FJ, Mégarbane B, Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med. 2007;25:551-8.
50. Borron SW, Arias JC, Bauer CR, Sánchez M, Fernández M, Jung I. Hemodynamics after intraosseous administration of hydroxocobalamin or normal saline in a goat model. Am J Emerg Med. 2009;27:1065-71.
51. Erdman AR. Is hydroxocobalamin safe and effective for smoke inhalation? Searching for guidance in the haze. Ann Emerg Med. 2007;49:814-6.
52. Kung SW, Chan YC, Lau FL Hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med. 2008;51:108.
53. Baud FJ, Favier C, Borron SW, Benaissa L. Are soot deposits and neurological disturbances predictive of cyanide poisoning in fire victims? J Toxicol Clin Toxicol. 1999;37:398-9.